Photo of Wendi Rogaliner

Wendi Rogaliner’s practice focuses on complex regulatory and compliance matters in the healthcare industry. She has extensive experience in regulatory compliance matters, including service as a legal IRO for entities under a corporate integrity agreement with the Office of Inspector General, and is routinely called upon to advise her institutional clients in their day to day operations and transactions within the heavily regulated healthcare industry.

This summer, a proposed amendment to the Controlled Substances Act known as the Cooper Davis Act (the “act”) is making its way through congressional approvals and causing growing dissension between and among parents, consumer safety advocates, and anti-drug coalitions on one hand, and the DEA, privacy experts, and constitutional scholars on the other.

As currently